Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
PubMed for id: 100289274
4 results
Results by year
Filters applied: . Clear all
Page 1
LncRNA DNAJC3-AS1 promotes the biological functions of papillary thyroid carcinoma via regulating the microRNA-27a-3p/CCBE1 axis.
Cell Biol Int. 2023 Mar;47(3):539-547. doi: 10.1002/cbin.11946. Epub 2022 Dec 30.
Cell Biol Int. 2023.
PMID: 36583660
miRNA-144 targeting DNAJC3-AS1 reverses the resistance of the breast cancer cell line Michigan Cancer Foundation-7 to doxorubicin.
Ren R, Yuan Z, Xu Z.
Ren R, et al.
Bioengineered. 2021 Dec;12(2):9885-9892. doi: 10.1080/21655979.2021.1999373.
Bioengineered. 2021.
PMID: 34895046
Free PMC article.
Item in Clipboard
LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis.
Na XY, Hu XQ, Zhao Y, Hu CH, Shang XS.
Na XY, et al.
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1291-1301. doi: 10.26355/eurrev_202102_24833.
Eur Rev Med Pharmacol Sci. 2021.
PMID: 33629299
Free article.
Item in Clipboard
SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity.
Shi P, Guo Y, Su Y, Zhu M, Fu Y, Chi H, Wu J, Huang J.
Shi P, et al.
J Immunol. 2020 Jul 1;205(1):168-180. doi: 10.4049/jimmunol.2000053. Epub 2020 May 11.
J Immunol. 2020.
PMID: 32393512
Item in Clipboard
Cite
Cite